Gene: TNRC18
Official Full Name: trinucleotide repeat containing 18provided by HGNC
Gene Summary: Predicted to enable chromatin binding activity. Located in cytosol; mitochondrion; and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24763 | TNRC18 Knockout cell line (HeLa) | Human | TNRC18 | 1:3~1:6 | Negative | Online Inquiry |
KO24764 | TNRC18 Knockout cell line (HCT 116) | Human | TNRC18 | 1:2~1:4 | Negative | Online Inquiry |
KO24765 | TNRC18 Knockout cell line (HEK293) | Human | TNRC18 | 1:3~1:6 | Negative | Online Inquiry |
KO24766 | TNRC18 Knockout cell line (A549) | Human | TNRC18 | 1:3~1:4 | Negative | Online Inquiry |
TNRC18 Gene Knockout Cell Lines are genetically modified cell lines designed to specifically disrupt the TNRC18 gene, which is implicated in various cellular processes, including transcriptional regulation and chromatin remodeling. By employing advanced CRISPR/Cas9 technology, these cell lines offer researchers the ability to study the functional roles of TNRC18 in a controlled laboratory setting. The knockout mechanism involves specific alterations to the DNA sequence of the TNRC18 gene, resulting in a loss-of-function effect that allows scientists to investigate the gene's contributions to cellular behavior, gene expression regulation, and potential links to diseases such as cancer.
The scientific importance of TNRC18 Gene Knockout Cell Lines extends to their applications in both basic and translational research. These models are invaluable for elucidating the gene's role in critical biological pathways and understanding its potential as a therapeutic target. In clinical settings, insights gained from studying these knockout lines can lead to the development of novel strategies for disease intervention, enhancing the potential for biomarker discovery and personalized medicine approaches.
Compared to traditional cell lines or other genetic modification techniques, TNRC18 Gene Knockout Cell Lines offer superior specificity and efficiency in gene disruption. They provide a reliable platform that minimizes off-target effects, allowing for more targeted experimentation. The elimination of TNRC18 function can yield significant insights without the confounding effects often associated with alternative models.
For researchers and clinicians, the value of TNRC18 Gene Knockout Cell Lines lies in their ability to facilitate exploration of gene function with a clear and direct impact on understanding disease mechanisms and developing targeted therapies. Our company is committed to providing high-quality biological products backed by rigorous research and development, ensuring that scientists have the best tools at their disposal to advance their work in cellular and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.